Reticare
Cambridge, US · Founded 2014 · Delaware corporation · 1 known investors
Reticare develops patented optical filters (RetiNaut) that selectively reduce blue light (380–500 nm) and high-energy green light (500–590 nm) emitted by phone, tablet and computer screens to lessen eye strain. The screen-protection products are based on over 20 years of research led by Dr. Celia Sánchez-Ramos at Universidad Complutense de Madrid and are sold to consumers.
Also known as reticare® · RetiNaut
Founders & leadership
Reticare was founded in 2014 by Celia Sánchez-Ramos.
Investors · 1
Reported raises · per SEC filings
Form D private placements$100K disclosed across 1 round · 2015
▶$100KraisedMar 2015 · 1 investors · ManufacturingRule 506(b)
- Roque GarciaExecutive Officer, Director
- Nilo GarciaExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $100K
- Minimum investment
- $100K
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Company profile
researched Aug 2026Reticare develops and sells optical filtering products intended to reduce the blue light (380–500 nm) and high-energy green light (500–590 nm) emitted by LED screens on phones, tablets and computers. The product line comprises adhesive screen protectors, priced from €17.90, and a range of RetiNaut eyewear: non-prescription glasses (€229), fixed-dioptre reading glasses for close-up screen work (€269) and full prescription replacement lenses with the RetiNaut filter integrated (€469). Each eyewear model is offered in two filter intensities — Clear, described as maximising transparency for daily use, and Intensive, aimed at long sessions or higher light sensitivity. The company states its filters reduce the targeted spectral bands without darkening the image or altering colour perception.
The technology is presented as the outcome of more than 20 years of scientific research at the Universidad Complutense de Madrid (UCM), carried out under the scientific supervision of Dr. Celia Sánchez-Ramos, whose research group studies the effects of high-energy light on in vitro and in vivo retinal cell models. The company cites UCM studies describing increases in retinal cell death of up to 23% under high-energy light exposure models, and states that the filter technology is covered by an international patent. Eyewear is described as manufactured in Spain and weighing approximately 28 grams. Reticare also publishes a blog on screen light and visual health, with posts authored by Mª Isabel Gil Adsuar and Nilo Garcia.
Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Legal entities · 1
corporate structure▸Research sources · 1
primary sources listed
- Reticarereticare.com · web
1 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Reticare do?
- Reticare sells patented optical filters and eyewear that selectively reduce blue and high-energy green light from screens.
- Who founded Reticare?
- Reticare was founded by Celia Sánchez-Ramos in 2014.
- Who are Reticare's investors?
- Reticare's investors include Stage 1 Ventures.
- How much funding has Reticare raised?
- Reticare has disclosed $100K raised across 1 round.
- Where is Reticare headquartered?
- Reticare is headquartered in Cambridge, US.